2011 - TID Conference


BACTERIA

4.1 - Multidrug Resistant Pseudomonas in Solid Organ Transplant Recipients

Presenter: Christian, van Delden, Geneva, Switzerland
Authors: Christian van Delden, Geneva, Switzerland


4.1 ‑Multidrug Resistant Pseudomonas aeruginosa
in Solid Organ transplant Recipients
Christian van Delden, Geneva, Switzerland

Persistent colonization and infections with MDR Pseudomonas aeruginosa have been reported especially for lung, but also renal and liver transplant recipients. Pre-transplant colonization of CF-lung transplant recipients by MDR P. aeruginosa has been reported as high as 52%, with a post-transplant rise up to 75%. Independent of its resistance phenotype P. aeruginosa might also impact survival of lung transplant recipients by favoring the development of bronchiolitis obliterans (BOS). Mortality of MDR P. aeruginosa bacteremia among transplant recipients is high reaching 40%.

Repeated exposure to antimicrobial therapies is frequent after transplantation and not only increases the risk for colonization by antibiotic susceptible P. aeruginosa, but also by MDR P. aeruginosa isolates.

Treatment for MDR P. aeruginosa infections in solid transplant recipients remains controversial. There are no controlled trials of treatment for MDR P. aeruginosa specifically in these patients. Most transplant centers use combination therapies including two or three different classes (beta-lactam + aminoglycoside +/- fluoroquinolone) of antimicrobials. The role of colistin either as adjunctive aerosolized therapy, or as intravenous mono- or combination therapy remains unclear.

In this presentation we will focus on the epidemiology, risk factors, outcome and treatment options for these challenging infections.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi